Content
Prescription weight loss that puts you first

Reviewed by Lynn Marie Morski, MD, JD
Written by Hadley Mendelsohn
Published 08/16/2024
Updated 12/31/2025
Key Takeaways:
Mounjaro® for weight loss is often pricey, especially without insurance.
Monthly costs frequently exceed $1,000.
The medication is FDA-approved for type 2 diabetes, and insurance coverage is usually only for people who have diabetes.
Manufacturer savings cards and pharmacy discount programs may lower Mounjaro® costs for some people, but eligibility is limited.
If Mounjaro® isn’t accessible, alternatives like Wegovy® or lower-cost weight loss medications may be worth exploring.
Mounjaro® (tirzepatide) can be expensive, especially without insurance. For many people, the monthly cost can exceed $1,200, making price a key factor when deciding whether the medication is realistic long-term.
The final cost of Mounjaro® depends on several factors, including insurance coverage, pharmacy pricing, and whether you qualify for manufacturer discounts or savings programs.
We’ll break down what Mounjaro® costs with and without insurance, how to lower out-of-pocket expenses, and which alternative weight loss medications may be more affordable.
Content
Mounjaro® is a medication approved by the Food and Drug Administration (FDA) for type 2 diabetes. It’s also commonly prescribed off-label for weight loss. Off-label use means a medication is prescribed for a purpose other than its FDA-approved indication, based on clinical judgment and patient needs.
It works by activating two hormones involved in appetite and blood sugar (glucose) regulation, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide). These hormones can help people feel fuller for longer and reduce overall food intake when paired with lifestyle changes.
Mounjaro® also helps improve glucose levels by:
Promoting insulin release from the pancreas when blood sugar levels are high
Reducing how much glucose the liver makes
Research suggests tirzepatide can be highly effective as a weight loss medication. One large systematic review found that it led to greater weight loss than several other medications, including other GLP-1s.
→ Learn more: Guide to Diabetes Medications for Weight Loss
According to Eli Lilly, the manufacturer of Mounjaro®, the list price is $1,079.77 per month. But the cost of Mounjaro® can vary based on a few factors, including:
Why it’s prescribed. If Mounjaro® is prescribed for type 2 diabetes, insurance may cover part of the cost. Coverage is generally less likely when it’s prescribed off-label, such as for weight loss.
Your insurance plan. Even with insurance, copays and prior authorization requirements can differ from plan to plan, which can affect what you pay out of pocket.
Where you fill the prescription. Prices may vary among pharmacies, including big in-store retail chains vs. independent or mail-order pharmacies.
Eligibility for savings programs. Some people may qualify for manufacturer savings cards or pharmacy discount programs, which can significantly lower Mounjaro® monthly costs.
Since pricing and coverage can change, it’s a good idea to check directly with your insurance provider and pharmacy to get the most accurate estimate of what Mounjaro® might cost for you.
Depending on the pharmacy, the monthly Mounjaro® cost might be between $900 and $1,200 for a package of four injection pens (one for each week of the month). If it isn’t covered by insurance, Mounjaro® out-of-pocket costs can be up to $12,000 a year.
If you have prescription insurance, consult your plan first to understand your coverage details, potential cost-saving benefits for the medication, and your eligibility.
If you have type 2 diabetes, Mounjaro® is FDA-approved for that use. Many insurance plans may cover it in this case, often with a copay or after prior authorization. Your out-of-pocket cost will depend on factors like your deductible, cost-sharing level in your insurance plan (formulary tier), and whether your plan requires step therapy.
Even with insurance, what you pay can range widely:
Some people pay $0 to $100 a month after insurance coverage and copays.
Others may still pay hundreds of dollars if insurance coverage is limited or denied.
Coverage is less common when Mounjaro® is prescribed off-label for weight loss. In those cases, many insurers either won’t cover the medication at all or require you to pay for most of the cost yourself.
The best way to understand your cost is to check your plan’s drug formulary or ask whether Mounjaro® requires prior authorization for your diagnosis.
Medicare generally doesn’t cover medications prescribed solely for weight loss. However, Mounjaro® might be covered under Medicare Part D if it’s prescribed for an FDA-approved use, such as type 2 diabetes, depending on your specific plan.
Medicaid coverage varies by state. Medicaid covers Mounjaro® in most instances if you have diabetes and get prior authorization.
A growing number of states are starting to expand coverage for GLP-1 medications for obesity treatment. Still, access and eligibility rules differ widely.
Since coverage rules can change and depend on how the medication is prescribed, it’s best to check directly with your Medicare or Medicaid plan. You can also ask your healthcare provider or pharmacist for advice. Or go to Mounjaro.lilly.com for more information.
We can’t tell you which insurance company covers Mounjaro® for sure because it can vary. That said, insurance providers are much more likely to cover it for type 2 diabetes treatment than for weight loss.
But don’t worry — there are other ways to reduce the cost of Mounjaro®, regardless of whether you have insurance.
We searched for Mounjaro® weight loss prices using the drug pricing and coupon sites Optum Perks and GoodRx.
Mounjaro® costs vary depending on pharmacy location, dose, and the amount of Mounjaro® you request. Pricing can change over time, but the site’s Mounjaro® coupons never expire.
At the time of publishing, these are the prices for a 1-month supply of Mounjaro® in San Francisco, California.
Dose in milligrams per milliliter (mg/mL) | 2.5mg/0.5mL | 5 mg/0.5 mL | 7.5 mg/0.5 mL | 10 mg/0.5 mL | 12.5 mg/0.5 mL | 15 mg/0.5 mL |
|---|---|---|---|---|---|---|
Walgreens | $1,297 | $1,297 | $1,297 | $1,297 | $1,291 | $1,290 |
Safeway | $1,093 | $1,093 | $1,085 | $1,077 | $1,077 | $1,083 |
CVS | $1,274 | $1,274 | $1,274 | $1,274 | $1,274 | $1,274 |
Walmart | $1,297 | $1,297 | $1,297 | $1,297 | $1,297 | $1,297 |
Other pharmacies | $995-1,425 | $995-1,425 | $995-1,425 | $995-1,425 | $995-1,425 | $995-1,425 |
Alternatively, you can apply for a Mounjaro® Savings Card if you’re prescribed the medication for type 2 diabetes. This discount card could potentially get you up to 85 percent off the standard cost of the drug. Some people might even be set up on a plan to pay $25 for a 1-month or 3-month prescription.
A Mounjaro® Savings Card can offer you a maximum savings of:
$150 per prescription for a 1-month supply
$300 per prescription for a 2-month supply
$450 per prescription for a 3-month supply
This comes out to a separate maximum annual savings of up to $1,800 per calendar year.
To be eligible for the Mounjaro® Savings Card, you must:
Live in the United States or Puerto Rico
Currently have a Mounjaro® prescription for type 2 diabetes
Currently have health insurance that doesn’t cover the medication
Not have Medicare as your insurance
Check your health insurance policy to confirm whether the drug is covered under your plan. If you meet all those criteria, you can then sign up for the Savings Card.
Here’s how the process works:
Visit the official website. Click on the “Savings & Resources“ section on the Mounjaro® website.
Select “Get Savings Card.“ Click this button to begin the enrollment process.
Fill out the online form. You’ll be asked to provide basic information, including insurance details.
Download or save your card. The card is typically available immediately for those eligible. You can download it, email it to yourself, or add it to a mobile wallet to use at participating pharmacies.
A Mounjaro® Savings Card generally can’t be used for off-label prescriptions, including for weight loss, and eligibility rules may change. Always review the full terms on the manufacturer’s website.
It’s unlikely you’ll get your insurance provider to cover Mounjaro® for weight loss if you don’t have type 2 diabetes.
Even if you have diabetes and your insurance company says Mounjaro® is covered for this purpose, it might require confirmation of a diabetes diagnosis before approving coverage for the medication.
You may not be able to convince your insurance company to cover a Mounjaro® prescription. But here are some things you can consider doing to boost your chances:
Make an appointment with your healthcare provider. The possibility of getting a prescription calls for a conversation with your medical provider. This ensures an official record is in place showing that you discussed your health and medical treatment needs.
Check your insurance plan formulary. The formulary explains your prescription medication coverage options and disclaimers, including whether Mounjaro® is listed as something your plan includes. If it’s not listed, you can request that your plan add it through its exceptions process.
Get a prior authorization. Some insurance companies require prior authorization for Mounjaro®. This means your healthcare provider will need to send in documentation that you have a type 2 diabetes diagnosis and a medical need for this medication.
Consider an appeal. If your initial request for Mounjaro® coverage is denied, you can file an appeal with your insurance provider. An appeal means your healthcare provider submits a letter explaining why you need the medication. Your insurance may not budge, but it’s worth a shot.
If your insurance won’t cover Mounjaro® and you can’t find a good savings option to bring the price of Mounjaro® down enough, there are alternative medications to explore.
Other GLP-1 injections available through the Hers platform include:
Wegovy®. Wegovy® (semaglutide) is a once-weekly subcutaneous injection. It’s FDA-approved for weight loss in people with obesity or with overweight and a weight-related health condition, like high blood pressure (hypertension) or sleep apnea.
Ozempic®. This once-weekly injection contains the active ingredient semaglutide and is FDA-approved to treat type 2 diabetes. It’s sometimes prescribed off-label to support weight management.
Compounded semaglutide.* This is a personalized, non-FDA-approved alternative to brand name GLP-1s. Through Hers, compounded semaglutide starts at $199 a month with a 6-month plan paid upfront in full.
Generic liraglutide. Liraglutide is the active ingredient in Saxenda® and Victoza®, which are approved for weight management and type 2 diabetes, respectively.
Hers also offers access to oral medication kits that help promote weight loss.* These kits start at $89 a month, making them far easier on your wallet than full-price Mounjaro®.
Hers oral medication kits typically contain a personalized combination of these drugs:
Naltrexone. Naltrexone is a prescription medication that helps reduce cravings for alcohol and opioids. It can also help with chronic weight management when combined with other drugs.
Metformin. Metformin is approved to treat type 2 diabetes. It’s sometimes prescribed off-label for polycystic ovary syndrome (PCOS), overweight, and obesity. Metformin works by improving insulin sensitivity.
Topiramate. Topiramate is an anticonvulsant that can reduce appetite and energy consumption.
Bupropion. Bupropion is an antidepressant that affects neurotransmitters that regulate the brain’s reward system.
*Compounded drug products aren’t approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required. Oral medication kits are compounded drugs.
Mounjaro® can be an effective option for weight management, but its cost is a major consideration for many people. What you’ll pay depends on factors like insurance coverage, pharmacy pricing, and whether you qualify for savings programs.
If Mounjaro® isn’t affordable or isn’t the right fit, other weight loss treatments — including FDA-approved alternatives and oral medications — may offer more accessible options. A licensed healthcare provider can help you compare costs, benefits, and risks to find the approach that best aligns with your health goals and budget.
Hers is committed to making weight loss medications as accessible and affordable as possible. Explore your options through our telehealth platform.
See answers to frequently asked questions about how much Mounjaro® costs.
The list price for Mounjaro® is $1,079.77 per month. Without insurance, Mounjaro® typically costs between $900 and $1,200 a month, depending on the pharmacy. With insurance, some people pay as little as $0 to $100. Others may still pay hundreds of dollars if coverage is limited or denied.
Mounjaro® is expensive due to high demand, limited insurance coverage for off-label use like weight loss, and the complexity of manufacturing injectable GLP-1 medications. Intermittent shortages have also contributed to higher out-of-pocket prices.
If Mounjaro® isn’t affordable, a healthcare provider can help you explore alternatives. This may include FDA-approved weight loss medications like Wegovy® or lower-cost oral or compounded options that may be more accessible long-term.
No, there’s currently no FDA-approved generic version of Mounjaro®. Since it’s a newer medication, it’s still protected by patents, meaning lower-cost generics aren’t available yet.
Usually, no, you can’t use the Mounjaro® Savings Card for weight loss. The manufacturer’s Savings Card is generally limited to people using Mounjaro® for type 2 diabetes with commercial insurance. It typically can’t be used for off-label weight loss prescriptions or with Medicare or Medicaid.
→ Read next: How Much Does Semaglutide Cost With and Without Insurance?
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
This article is for informational purposes only and does not constitute medical advice. The information contained herein is not a substitute for and should never be relied upon for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. Learn more about our editorial standards here.
Full Name: Lynn Marie Morski, MD, JD
Current Role at Hims & Hers: Medical Advisor
Education:
Juris Doctor - Thomas Jefferson School of Law, 2014
Doctor of Medicine - Saint Louis University School of Medicine, 2005
Training:
Primary Care Sports Medicine Fellowship - University of Arizona, 2009
Family Medicine Residency - Mayo Clinic - 2008
Medical Licenses:
California, 2010
Board Certifications:
Affiliations & Memberships:
Specialties & Areas of Focus:
Mental Health, Primary Care, Psychedelic Medicine
Years of Experience: 11
Previous Work Experience:
Physician & Subinvestigator/Clinician Rater - Kadima Neuropsychiatry Institute, January 2025–
Investigator - Elite Clinical Network, June 2024–
Physician - Veterans Administration, 2010–2019
Publications & Research:
Morski LM. Invited Commentary on Psychedelic Therapy: A Primer for Primary Care Clinicians. Am J Ther. 2024;31(2):e183-e185. https://journals.lww.com/americantherapeutics/citation/2024/04000/invited_commentary_on_psychedelic_therapy__a.9.aspx
Grover, M., Anderson, M., Gupta, R., Haden, M., Hartmark-Hill, J., Morski, L.M., Sarmiento, Dueck, A. Increased osteoporosis screening rates associated with the provision of a Periodic Health Examination. J Am Board Fam Med November-December 2009 vol. 22 no. 6 655-662. https://www.jabfm.org/content/22/6/655.long
Morski, L.M., Bratton,R.L. and DeBrino, G. Older Man With Fever and Tender Rash. Consultant, 2009, May 49(5). https://www.consultant360.com/content/older-man-fever-and-tender-rash
Medical Content Reviewed & Approved:
List pages or topics the expert has reviewed for accuracy
Quotes or Expert Insights:
Mental health care isn’t a luxury, it’s a fundamental part of overall well-being. We all deserve mental health support that’s evidence-based, accessible, and affordable.
Media Mentions & Features:
A User’s Guide to Therapeutic Psychedelics: From magic mushrooms to MDMA and ayahuasca to ibogaine—everything you need to know before (and after) taking the leap - Oprah Daily, May 6, 2024
Why I Practice Medicine:
I'm passionate about helping people access reliable, affordable healthcare—without stigma or unnecessary barriers. Everyone deserves to feel informed and empowered when it comes to their health!
Hobbies & Interests:
Salsa dancing, drumming, surfing, scuba diving, triathlons
Professional Website or Profile: https://www.morskiconsulting.com/, https://psychedelicmedicineassociation.org/
Obesity
Diabetes
Fatty Liver Disease
Cardiovascular Disease
Hypertension
Insulin Resistance